论文信息 - Neonatal tetanus in Peru: risk assessment with modified enzyme-linked immunosorbent assay and toxoid skin test.

Neonatal tetanus in Peru: risk assessment with modified enzyme-linked immunosorbent assay and toxoid skin test.

We used a modified enzyme-linked immunosorbent assay (ELISA) to investigate tetanus immunity in 232 pregnant Peruvian women. One hundred forty-two (61.2%) had protective antitoxin titers (> or = 0.01 IU/mL). Protective titers correlated positively with the number of toxoid doses reported during the current pregnancy. A majority of women reporting no toxoid doses during the current pregnancy had at least one prenatal health care visit. We evaluated a toxoid skin test in 44 of the subjects, but it correlated poorly with the ELISA. The modified ELISA is a useful in vitro method for studying tetanus immunity in the developing world.

[1] L. Réthy. ACTIVE ANTI-TETANUS IMMUNISATION OF FEMALES TO CONTROL NEONATAL TETANUS , 1986, The Lancet.

[2] Indira Narayanan,et al. Evaluation of cutaneous response to tetanus antigen to document immunization: preliminary observations. , 1985, Indian Pediatrics.

[3] K. Kjeldsen,et al. IMMUNITY AGAINST TETANUS AND EFFECT OF REVACCINATION 25-30 YEARS AFTER PRIMARY VACCINATION , 1984, The Lancet.

[4] F. Pacini,et al. Decreased Levels of Helper T Cells: A Possible Cause of Immunodeficiency in Pregnancy , 1982, The New England journal of medicine.

[5] F. Dastur,et al. RESPONSE TO SINGLE DOSE OF TETANUS VACCINE IN SUBJECTS WITH NATURALLY ACQUIRED TETANUS ANTITOXIN , 1981, The Lancet.

[6] S. Grover,et al. Sero-survey of diphtheria and tetanus antitoxin. , 1978, The Indian journal of medical research.

[7] J. Bellanti,et al. Impaired in vitro cell-mediated immunity to rubella virus during pregnancy. , 1973, The New England journal of medicine.

[8] P. Fireman,et al. Hypersensitivity to tetanus toxoid. , 1973, The Journal of allergy and clinical immunology.

[9] O. Simonsen,et al. ELISA for the routine determination of antitoxic immunity to tetanus. , 1986, Journal of biological standardization.

[10] K. Newell,et al. The use of toxoid for the prevention of tetanus neonatorum. Final report of a double-blind controlled field trial. , 1966, Bulletin of the World Health Organization.